Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianpu Chemicals, formerly known as Hercules Tianpu Chemicals, is a leading Chinese manufacturer of cellulose ethers, including Methylcellulose (MC), Hydroxypropyl Methylcellulose (HPMC), and Hydroxyethyl Cellulose (HEC). Established as a joint venture between Hercules Incorporated (now part of Ashland) and Chinese partners, the company specializes in high-quality pharmaceutical excipients used in tablet coatings, controlled-release drug delivery systems, and as stabilizers in various formulations. With major production facilities in Zhangjiagang and Luzhou and a technology center in Shanghai, it serves a global market across the pharmaceutical, food, and construction sectors. The company is recognized for its advanced manufacturing technologies and is one of the most influential suppliers of cellulose derivatives in the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hercules Tianpu.